Ignite Creation Date:
2024-05-06 @ 12:40 AM
Last Modification Date:
2024-10-26 @ 10:53 AM
Study NCT ID:
NCT01628887
Status:
TERMINATED
Last Update Posted:
2013-07-16
First Post:
2012-06-25
Brief Title:
Feasibility of a Supportive Education Program for Latina Breast Cancer Survivors
Sponsor:
City of Hope Medical Center
Organization:
City of Hope Medical Center
Study Overview
Official Title:
Feasibility of a Supportive Education Program for Latina Breast Cancer Survivors
Status:
TERMINATED
Status Verified Date:
2013-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Proposal will not be submitted and low accrual
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This clinical trial studies a supportive education program for Latina breast cancer survivors The Bilingual Breast Cancer Education Intervention BBCEI may help Latina breast cancer survivors know what to expect after completing breast cancer treatment and prepare them to cope with cancer related survivorship issues
Detailed Description:
PRIMARY OBJECTIVES I Describe the feasibility of implementing the BBCEI II Describe the cultural and linguistic appropriateness of the BBCEI III Determine topics requiring further emphasis in the BBCEI IV Identify ways to enhance program content format and materials OUTLINE Participants undergo 2 tailored BBCEI sessions within 1 month At the beginning of the first session the research nurse will present the participants with a list of common physical and social concerns The participant will then be asked to identify 3 topics that she wants to discuss The research nurse will discuss with the participant any relevant supportive care resources and make the appropriate referrals At the second session the focus of the BBCEI will be on psychological and spiritual well-being
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None